Related Experiment Video
Updated: Jun 11, 2026

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Design, synthesis and evaluation of lantadene A congener with hydroxyl functionality in ring A as an antitumour agent
Manu Sharma1, Anurag Rakhi, Nandita Dalal
1Department of Biotechnology and Bioinformatics, Jaypee University of Information Technology, Solan 173215, Himachal Pradesh, India. lantadene@hotmail.com
Abstract:
Pentacyclic triterpenoid lantadene A congener with hydroxyl functionality in ring A was designed and synthesised on the basis of enhancement of polarity and bioactivity. The new synthesised compound 22β-angeloyloxy-methyl-2-hydroxy-3-oxoolean-1,12-dien-28-oate (6) was screened for cytotoxicity against human cancer cell lines (HL-60, HeLa, Colon 502713 and A-549) and showed a better cytotoxicity than the parent compound (p<0.05). Further, compound 6 was screened for in vivo antitumour activity in a two-stage squamous cell carcinogenesis model, using female Swiss albino mice. Compound 6 showed a better tumour inhibition profile than the parent compound. Compound 6 also exhibited a marked decrease in protein expression of activator protein-1 (c-jun), nuclear factor-kappa B (p65) and p55. The results inferred that an increase in polarity of the lead molecule not only increased the antitumour activity but also reduced the dose, which may be linked to the deregulation of the abovementioned molecular targets, and warrants further optimisation of the structure to make it a drug-like candidate.
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Antiprotozoal Agents
Diazonium Group Substitution: –OH and –H
Antifungal Agents
Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
